Tumor context determines ARID1A effects on gastric cancer immunity
The role of ARID1A in cancer immune evasion remains uncertain, with prior studies reaching opposing conclusions. In addition, previous work has shown that the role of ARID1A in cell-autonomous tumorigenesis is context-dependent. Using isogenic murine gastric cancer models, we found that in vivo Arid1a loss in an autochthonous genetically engineered mouse model of gastric cancer conferred T cell-dependent immune evasion, while in vitro deletion did not. Mechanistically, tumor Arid1a loss reprogrammed the tumor microenvironment into an immune desert through suppression of GM-CSF secretion and interferon-{gamma} responsiveness. These changes were not observed when Arid1a was deleted in vitro. In human gastric cancer, an immune-cold phenotype was restricted to ARID1A mutants in the genomically stable subtype, while ARID1A loss in the chromosomal instability subtype was associated with variable immune profiles. These results demonstrate that tumor ARID1A loss does not intrinsically confer pro- or anti-tumor immune properties and instead is determined by tissue context.